Showing results (191-200 of 259) with videos related to

Sort By:
Pageof 26
Clinical Breast Cancer|May 17, 2011
Sunitinib plus paclitaxel versus bevacizumab plus paclitaxel for first-line treatment of patients with advanced breast cancer: a phase III, randomized, open-label trialNicholas J Robert, Mansoor N Saleh, Devchand Paul, et al.
JCO Global Oncology|February 2, 2021
Expected Medium- and Long-Term Impact of the COVID-19 Outbreak in OncologyConcetta Elisa Onesti, Marco Tagliamento, Giuseppe Curigliano, et al.
Gene|July 20, 2024
Assessing the efficacy of an innovative diagnostic method for identifying 5 % variants in somatic ctDNAChiara Mareso, Luca Crosta, Mattia Giovanna De Vita, et al.
The Lancet. Oncology|September 9, 2019
Endocrine treatment versus chemotherapy in postmenopausal women with hormone receptor-positive, HER2-negative, metastatic breast cancer: a systematic review and network meta-analysisMario Giuliano, Francesco Schettini, Carla Rognoni, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 20, 2011
Sensitization of BCL-2-expressing breast tumors to chemotherapy by the BH3 mimetic ABT-737Samantha R Oakes, François Vaillant, Elgene Lim, et al.
Plos One|January 17, 2023
Immune-related pan-cancer gene expression signatures of patient survival revealed by NanoString-based analysesAlberto D'Angelo, Huseyin Kilili, Robert Chapman, et al.
The Oncologist|August 23, 2024
Next-generation sequencing-based evaluation of the actionable landscape of genomic alterations in solid tumors: the "MOZART" prospective observational studyFrancesco Schettini, Marianna Sirico, Marco Loddo, et al.
Targeted Oncology|September 24, 2022
Safety and Efficacy of Ribociclib in Combination with Letrozole in Patients with HR+, HER2- Advanced Breast Cancer: Results from the Italian Subpopulation of Phase 3b CompLEEment-1 StudyMichelino De Laurentiis, Roberta Caputo, Manuelita Mazza, et al.
Journal of the National Cancer Institute|May 15, 2020
Overall Survival of CDK4/6-Inhibitor-Based Treatments in Clinically Relevant Subgroups of Metastatic Breast Cancer: Systematic Review and Meta-AnalysisFrancesco Schettini, Fabiola Giudici, Mario Giuliano, et al.
Plos One|August 8, 2019
Neoadjuvant eribulin mesylate following anthracycline and taxane in triple negative breast cancer: Results from the HOPE studySerena Di Cosimo, Nicla La Verde, Anna Moretti, et al.
Pageof 26